Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-02
1988-10-04
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548180, 548183, C07D41712, A61K 31425
Patent
active
047756870
ABSTRACT:
A thiazolidinedione derivative of the general formula: ##STR1## wherein X is an oxygen or sulfur atom, R.sup.1 and R.sup.2 each independently is hydrogen or a hydrocarbon residue which may optionally be substituted and R.sup.1 and R.sup.2 may jointly, together with the oxazole or thiazole ring, form a condensed ring and A is a lower alkylene group; or a salt thereof, are novel compounds, which exhibit in mammals blood sugar- and lipid-lowering activity, and are of value as a therapeutic agent for diabetes and/or therapeutic agent for hyperlipemia.
REFERENCES:
patent: 4287200 (1981-09-01), Kawamatsu et al.
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4461902 (1984-07-01), Kawamatsu et al.
patent: 4572912 (1986-02-01), Yoshioka
Sohda et al., Chem. Pharm. Bull., 30(10), 3563-3573, 3580-3600, (1982).
Fujita et al., Diabetes, vol. 32, 804-810, (1983).
Sohda et al., Chem. Pharm. Bull., 32(6), 2267-2278, (1984).
Fujita Takeshi
Meguro Kanji
Gerstl Robert
Takeda Chemical Industries Ltd.
LandOfFree
Thiazolidine derivatives, their production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidine derivatives, their production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine derivatives, their production and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2156650